Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Andalas obstetrics and gynecology journal
Morena, Sivia Heni
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Urinary KIM-1 Levels Normal Pregnancy vs Early-Onset Preeclampsia, and Late-Onset Preeclampsia Morena, Sivia Heni; Vaulinne Basyir; Husna Yetti
Andalas Obstetrics And Gynecology Journal Vol. 9 No. 2 (2025)
Publisher : Fakultas Kedokteran Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/aoj.9.2.213-223.2025

Abstract

Introduction : Preeclampsia is a hypertensive disorder of pregnancy that contributes to high maternal mortality rates. Kidney Injury Molecule-1 (KIM-1) has been identified as a potential biomarker for detecting kidney injury and is suspected to play a role in the pathogenesis of preeclampsia. Objective : This study to determine the differences in urinary KIM-1 levels among normal pregnancies, early-onset preeclampsia, and late-onset preeclampsia at Dr. M. Djamil General Hospital, Padang. Methods : Cross-sectional comparative study included 72 pregnant women, consisting of 24 with normal pregnancies, 24 with early-onset preeclampsia, and 24 with late-onset preeclampsia. Urinary KIM-1 levels were measured using the ELISA method at the Biomedical Laboratory, Faculty of Medicine, Andalas University. Results : The mean urinary KIM-1 levels in the normal pregnancy group were 2.834 ± 0.957 ng/mL, in the early-onset preeclampsia group were 2.659 ± 1.175 ng/mL, and in the late-onset preeclampsia group were 2.694 ± 0.978 ng/mL. Statistical analysis showed no significant difference in urinary KIM-1 levels among the three groups (p > 0.05). Conclusion : There was no significant difference in urinary KIM-1 levels between normal pregnancies, early-onset preeclampsia, and late-onset preeclampsia. Further studies with larger sample sizes and more specific methods are needed to explore the potential of KIM-1 as a preeclampsia biomarker.
Co-Authors Husna Yetti Vaulinne Basyir